Highlights and Quick Summary
- Annual 3Y Total Assets Growth (CAGR) for 2022 was -11.27% (a -150.02% decrease from previous year)
- Annual 3Y Total Assets Growth (CAGR) for 2021 was 22.53% (a 80.1% increase from previous year)
- Annual 3Y Total Assets Growth (CAGR) for 2020 was 12.51% (a -56.15% decrease from previous year)
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 3Y Total Assets Growth (CAGR) of DURECT Corporation
Most recent 3Y Total Assets Growth (CAGR)of DRRX including historical data for past 10 years.Interactive Chart of 3Y Total Assets Growth (CAGR) of DURECT Corporation
DURECT Corporation 3Y Total Assets Growth (CAGR) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | -11.27% |
| 2021 | – | – | – | – | 22.53% |
| 2020 | – | – | – | – | 12.51% |
| 2019 | – | – | – | – | 28.53% |
| 2018 | – | – | – | – | 2.25% |
| 2017 | – | – | – | – | 1.98% |
| 2016 | – | – | – | – | -0.26% |
| 2015 | – | – | – | – | 0.6% |
| 2014 | – | – | – | – | 0.6% |
| 2013 | – | – | – | – | -15.46% |
| 2012 | – | – | – | – | -0.6% |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic